Pharmacy Updates / Introduction
Search Options
Generic Drugs
Over-the-Counter Drugs
Non-Preferred Drugs
Prior Authorization
Relative Cost Indicators

Effective 10/01/2009
The Pharmacy and Therapeutics Committee approved the following changes to the Preferred Drug List.

Recently Added Drugs
Asmanex  
Avelox
Banzel (subject to step-therapy requirements)
Cefprozil
Celebrex (subject to prior authorization)
Cetrizine D
Econazole Cream
Fluvoxamine
Ketorolac Tablets (quantity limits apply)
Lyrica (subject to prior authorization)
Meloxicam
Mepron
Oxaprozin
Paramomycin
Paroxetine
Pristiq (subject to step-therapy requirements)
Ritalin LA (subject to step-therapy requirements)
Saizen (subject to prior authorization)
Strattera (subject to step-therapy requirements)
Suprax 400mg Tablet (quantity limits apply)
Symbicort (subject to step-therapy requirements)
Tev-Tropin (subject to prior authorization)
Utira-C
Ventolin HFA
Vesicare (subject to step-therapy requirements)
Zyvox (subject to prior authorization)
 
No Longer Requre Prior Authorization
Bupropion SR
Fluconazole
Lamotrigine
Topiramate
Zonisamide
 
Removed from Preferred Drug List
Albuterol Respules 1.25mg and 0.63mg (current users were grandfathered)
Alupent
Axid Solution (current users were grandfathered)
Azmacort (current users were grandfathered)
Buproban (generic Zyban - current users were grandfathered)
Ceclor-CD (no longer manufactured)
Condylox Gel
Diflunisal
Etodolac XL
Flurbiprofen
Furadantin Suspension (current users were grandfathered)
The following Growth Hormone Products:
  • Humatrope
  • Norditropin
  • Nutropin, Nutrpoin AQ
  • Serostim
 
Indomethacin Suspension
Indomethacin SR
Ketoprofen ER
Mephobarbital (current users were grandfathered)
Methenamine Mandelate (no longer manufactured)
Naproxen EC, Naproxen SA
Nardil (current users were grandfathered)
Oxytrol
ProAir HFA
Proventil HFA
Tolmetin
 
Modifications to the Preferred Drug List
Stimulant Age Edit - prior authorization is required for adults 21 years of age and older for the CNS Stimulants (e.g. Adderall XR, Amphetamine Salt Combination [Adderall], Concerta, Dextroamphetamine, Methylphenidate, Methylphenidate SR)
Quantity Limits - quantity limits will apply to the following:
  • Esgic, Esgic Plus - 180 tablets per month
  • Florinal, Florinal with Codeine - 180 tablets per month
  • Fioricet, Fioricet with Codeine - 180 tablets per month
  • Maxalt, Maxalt MLT - 9 per month
  • Ovide - 120 ml per month
  • Sumatripan (Imitrex) nasal spray - 6 units per month
 

Effective 09/01/2009
The Pharmacy and Therapeutics Committee approved the following changes to the Preferred Drug List.

No Longer Require Prior Authorization
Adderall XR - subject to a quantity limit of 1 capsule per day  
Please Note:
  • The preferred product is Brand Adderall XR
  • Generic Adderall XR remains Non-Preferred

Effective 08/01/2009
The Pharmacy and Therapeutics Committee approved the following changes to the Preferred Drug List.

Recently Added Drugs
Metoprolol Succinate (generic Toprol XL)  
Bisoprolol (generic Zebeta)
Quinapril (generic Accupril)
Quinapril HCT (generic Accuretic)
Simcor (Niacin/Simvastatin)
Micardis (subject to prior notification)
Micardis HCT (subject to prior notification)
Opana ER (subject to prior notification)
Crestor (subject to prior notification)
Prevacid (subject to prior notification)
 
No Longer Requre Prior Authorization
Omeprazole 10 mg caps, 20 mg caps/tabs (generic Prilosec, Prilosec OTC)
 
Require Prior Authorization
Frova  
Maxalt, Maxalt MLT
 
Removed from Preferred Drug List
Pentazocine HCl/Acetaminophen (generic Talacen)
Relpax
Zomig, Zomig ZMT
Altoprev
Sotalol HCl (Betapace AF)
Cardene SR
Benicar, Benicar HCT
Antara
Triglide
Aciphex
All strengths of Oxycodone HCl/Acetaminophen Caps and Tabs other than: 5/500 mg and 5/325 mg tablets and Tylox capsules
 

Effective 04/01/2009
The Pharmacy and Therapeutics Committee approved the following changes to the Preferred Drug List.

Recently Added Drugs
Cymbalta (subject to prior authorization)  
Humira (subject to prior authorization)
Hycamptin (subject to prior authorization)
Xenazine (subject to prior authorization)
 
No Longer Require Prior Authorization
Terbinafine (generic Lamisil); subject to quantity limit of 90 per 180 days

Recently Removed Drugs
Actonel; current users grandfathered
Fosamax plus D; current users grandfathered
Humulin products
Humalog products

All Novolin and Novolog products will remain on the Preferred Drug List

Current users of Humulin and Humalog products were directed to use the equivalent Novolin or Novolog product. For the Humulin/Humalog products where there was no equivalent Novolin/Novolog product (i.e. Humulin 50/50, Humalog mix 50/50), those users were grandfathered.

 

Preferred Drug List

This Preferred Drug List (PDL) is a compilation of drugs in various therapeutic classes for use in meeting the prescription therapy needs of enrollees in Medicaid and related UnitedHealthcare and AmeriChoice government-funded health care products. These include State Child Health Insurance Programs (SCHIP) and various programs for uninsured adults administered by AmeriChoice and UnitedHealthcare. Some of the medications included in the PDL are not covered for some enrollees. The list applies to prescriptions dispensed at network pharmacies. It does not include inpatient medications or drugs obtained from or administered in a physician’s office.